Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 1
1 (50.0%)Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM
Not Applicable
Recruiting
- Conditions
- Diabetes Type 2Hyperglycaemia (Diabetic)QT Interval, Variation inTorsades de Pointes
- Interventions
- First Posted Date
- 2025-06-11
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Richmond Pharmacology Limited
- Target Recruit Count
- 24
- Registration Number
- NCT07014735
- Locations
- 🇬🇧
Richmond Pharmacology Ltd., London, United Kingdom
Study to Collect High-Resolution ECG Data and Patient Insights on Heart Failure Care
Recruiting
- Conditions
- Heart Failure
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Richmond Research Institute
- Target Recruit Count
- 1000
- Registration Number
- NCT06809686
- Locations
- 🇬🇧
Richmond Pharmacology, London, United Kingdom
Food and Insulin Effect on QT/QTC Interval of ECG
Phase 1
Completed
- Conditions
- C-Peptide Effects on the QT/QTc IntervalEffects of Different Meals on the QT/QTc IntervalInsulin and Oral Hypoglycemic [Antidiabetic] Drugs Causing Adverse Effects in Therapeutic UseMoxifloxacin ECG Profile in Fed and Fasted StateJapanese vs. Caucasian TQT Comparison
- Interventions
- Other: FDA breakfastOther: Continental breakfastProcedure: Insulin ClampDrug: Placebo
- First Posted Date
- 2012-07-17
- Last Posted Date
- 2014-08-20
- Lead Sponsor
- Richmond Pharmacology Limited
- Target Recruit Count
- 32
- Registration Number
- NCT01642485
- Locations
- 🇬🇧
Richmond Pharmacology Ltd, London, Tooting, United Kingdom
News
No news found